Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors
Stopped early · Phase 1
Conditions studied: Solid Tumor, Adult, Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor
In brief
This is a first-in-human, open-label, multicenter, dose-escalation, safety, PK, and biomarker study of PBI-200 in subjects with NTRK-fusion-positive advanced or metastatic solid tumors.
Key facts
- Study ID
- NCT04901806
- Run by
- Pyramid Biosciences
- People needed
- 29
- Starts
- 2021-07-20
- Expected to finish
- 2023-07-26
- Last updated by the study team
- 2024-03-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- John Wayne Cancer Institute at St. Johns Health Center — Santa Monica, California, United States
- Stanford Hospital and Clinics — Stanford, California, United States
- Sarah Cannon Research Institute at HealthONE — Denver, Colorado, United States
- Florida Cancer Specialists — Lake Mary, Florida, United States
- Sylvester Comprehensive Cancer Center (University of Miami) — Miami, Florida, United States
- Miami Cancer Institute — Miami, Florida, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Westchester Medical Center — Hawthorne, New York, United States
- Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States
- Tennessee Oncology, PLLC — Nashville, Tennessee, United States
- The University of Texas MD Anderson Cancer Center — Houston, Texas, United States
- Peter MacCallum Cancer Centre — Melbourne, Victoria, Australia
- Rigshospitalet, University Hospital of Copenhagen — Copenhagen, Denmark
- Institut Bergonie — Bordeaux, France
- Centre Léon Bérard — Lyon, France
- Hopital Europeen Georges Pompidou — Paris, France
- CHU Poitiers - Hopital la Miletrie — Poitiers, France
- Institut Gustave Roussy — Villejuif, France
- Dr. Senckenberg Institute of Neurooncology — Frankfurt am Main, Germany
- Universitaetsklinikum Heidelberg — Heidelberg, Germany
- Marienhospital Herne — Herne, Germany
- Queen Mary Hospital — Pok Fu Lam, Hong Kong
- Prince of Wales Hospital — Shatin, Hong Kong
- Azienda Ospedaliero Universitaria delle Marche — Ancona, Italy
- IRCCS Ospedale San Raffaele — Milan, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.